Your browser doesn't support javascript.
loading
Clinical and pathogenic significance of S100A4 overexpression in systemic sclerosis.
Denton, Christopher P; Xu, Shiwen; Zhang, Fenge; Maclean, Rory H; Clark, Kristina E N; Borchert, Signe; Hussain, Rizwan I; Klingelhöfer, Jörg; Hallén, Jonas; Ong, Voon H.
Afiliação
  • Denton CP; Centre for Rheumatology, Division of Medicine, UCL, London, UK c.denton@ucl.ac.uk.
  • Xu S; Centre for Rheumatology, Division of Medicine, UCL, London, UK.
  • Zhang F; Centre for Rheumatology, Division of Medicine, UCL, London, UK.
  • Maclean RH; Centre for Rheumatology, Division of Medicine, UCL, London, UK.
  • Clark KEN; Centre for Rheumatology, Division of Medicine, UCL, London, UK.
  • Borchert S; Research Department, Arxx Therapeutics, Oslo, Norway.
  • Hussain RI; Research Department, Arxx Therapeutics, Oslo, Norway.
  • Klingelhöfer J; Research Department, Arxx Therapeutics, Oslo, Norway.
  • Hallén J; Research Department, Arxx Therapeutics, Oslo, Norway.
  • Ong VH; Centre for Rheumatology, Division of Medicine, UCL, London, UK.
Ann Rheum Dis ; 82(9): 1205-1217, 2023 09.
Article em En | MEDLINE | ID: mdl-37414521
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico Idioma: En Ano de publicação: 2023 Tipo de documento: Article